CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Lower urinary tract symptoms in men, age-related (including symptoms of benign prostatic hyperplasia/hypertrophy) - Evidence
Supporting evidence
The supporting evidence for the recommendations in this topic is summarized in the guideline The management of lower urinary tract symptoms in men published by the National Institute for Health and Clinical Excellence (NICE) [NICE, 2010].
- NICE summarized the evidence on benefits, cost-effectiveness, and adverse effects. NICE documented how the relative values of benefits and adverse events were weighed up, how economic considerations were taken into account, and how the reliability of evidence was assessed in terms of limitations in study design, and the consistency, applicability, and precision of the results.
© NHS Institute for Innovation and Improvement